SIE, SIES, GITMO evidence-based guidelines on novel agents (thalidomide, bortezomib, and lenalidomide) in the treatment of multiple myeloma
Ann. hematol; 91 (6), 2012
In this project, we produced drug-specific recommendations targeting the use of new agents for multiple myeloma (MM). We used the GRADE (Grades of Recommendation, Assessment, Development, and Evaluation) system which separates the judgments on quality of evidence from the judgment about strength of recom...
Antineoplastic Combined Chemotherapy Protocols, Antineoplastic Combined Chemotherapy Protocols/administration & dosage, Boronic Acids/therapeutic use, Bortezomib/therapeutic use, Hematology/legislation & jurisprudence, Hematology/methods, Lenalidomide/therapeutic use, Multiple Myeloma/pathology, Neoplasm Grading, Pyrazines/administration & dosage, Societies, Medical/legislation & jurisprudence, Thalidomide/therapeutic use